ArticleScientific reports2025
Metformin combined with CB-839 specifically inhibits KRAS-mutant ovarian cancer.
Han Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleScientific reports2025
Han Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.